Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 67

Cited In for PubMed (Select 17339622)

1.

Aspirin use associated with amyotrophic lateral sclerosis: a total population-based case-control study.

Tsai CP, Lin FC, Lee JK, Lee CT.

J Epidemiol. 2015;25(2):172-7. doi: 10.2188/jea.JE20140070. Epub 2014 Dec 27.

2.

The evolving role of nonsteroidal anti-inflammatory drugs in colon cancer prevention: a cause for optimism.

Rigas B, Tsioulias GJ.

J Pharmacol Exp Ther. 2015 Apr;353(1):2-8. Review.

PMID:
25589413
3.

Management of colorectal cancer.

Stintzing S.

F1000Prime Rep. 2014 Nov 4;6:108. doi: 10.12703/P6-108. eCollection 2014. Review.

4.

The association between dietary inflammatory index and risk of colorectal cancer among postmenopausal women: results from the Women's Health Initiative.

Tabung FK, Steck SE, Ma Y, Liese AD, Zhang J, Caan B, Hou L, Johnson KC, Mossavar-Rahmani Y, Shivappa N, Wactawski-Wende J, Ockene JK, Hebert JR.

Cancer Causes Control. 2015 Mar;26(3):399-408. doi: 10.1007/s10552-014-0515-y. Epub 2014 Dec 31.

PMID:
25549833
5.

Influence of NSAID Use Among Colorectal Cancer Survivors on Cancer Outcomes.

Johnson CC, Jankowski M, Rolnick S, Yood MU, Alford SH.

Am J Clin Oncol. 2014 Dec 10. [Epub ahead of print]

PMID:
25503426
6.

Molecular pathways: aspirin and Wnt signaling-a molecularly targeted approach to cancer prevention and treatment.

Gala MK, Chan AT.

Clin Cancer Res. 2015 Apr 1;21(7):1543-8. doi: 10.1158/1078-0432.CCR-14-0877. Epub 2014 Dec 11.

PMID:
25501125
7.

Primary prevention of colorectal cancer: myth or reality?

Crosara Teixeira M, Braghiroli MI, Sabbaga J, Hoff PM.

World J Gastroenterol. 2014 Nov 7;20(41):15060-9. doi: 10.3748/wjg.v20.i41.15060.

8.

Correlation between long-term aspirin use and F-fluorodeoxyglucose uptake in colorectal cancer measured by PET/CT.

Su B, Xu B, Wan J.

PLoS One. 2014 Oct 7;9(10):e109459. doi: 10.1371/journal.pone.0109459. eCollection 2014.

9.

Genetic variation in prostaglandin synthesis and related pathways, NSAID use and colorectal cancer risk in the Colon Cancer Family Registry.

Resler AJ, Makar KW, Heath L, Whitton J, Potter JD, Poole EM, Habermann N, Scherer D, Duggan D, Wang H, Lindor NM, Passarelli MN, Baron JA, Newcomb PA, Le Marchand L, Ulrich CM.

Carcinogenesis. 2014 Sep;35(9):2121-6. doi: 10.1093/carcin/bgu119. Epub 2014 Jun 7.

PMID:
24908683
10.

Ethnic disparities in the risk of colorectal adenomas associated with aspirin and statin use: a retrospective multiethnic study.

Davis-Yadley AH, Lipka S, Shen H, Shah H, Swarup S, Barnowsky A, Silpe J, Mosdale J, Pan Q, Fridlyand S, Sreeharshan S, Abraham A, Viswanathan P, Krishnamachari B.

J Gastrointest Oncol. 2014 Apr;5(2):112-8. doi: 10.3978/j.issn.2078-6891.2014.010.

11.

The association between circulating high-sensitivity C-reactive protein concentration and pathologic measures of colonic inflammation.

Joshu CE, Tsilidis KK, Peskoe SB, Giardiello FM, Dluzniewski PJ, Nelson WG, Iacobuzio-Donahue CA, Platz EA.

Cancer Causes Control. 2014 Apr;25(4):409-18. doi: 10.1007/s10552-014-0343-0. Epub 2014 Jan 17.

12.

Analgesic use and patterns of estrogen metabolism in premenopausal women.

Fortner RT, Oh H, Daugherty SE, Xu X, Hankinson SE, Ziegler RG, Eliassen AH.

Horm Cancer. 2014 Apr;5(2):104-12. doi: 10.1007/s12672-013-0167-5. Epub 2014 Jan 10.

13.

Pharmacological and dietary prevention for colorectal cancer.

Nolfo F, Rametta S, Marventano S, Grosso G, Mistretta A, Drago F, Gangi S, Basile F, Biondi A.

BMC Surg. 2013;13 Suppl 2:S16. doi: 10.1186/1471-2482-13-S2-S16. Epub 2013 Oct 8. Review.

14.

Prevalence of advanced colorectal neoplasia in white and black patients undergoing screening colonoscopy in a safety-net hospital.

Schroy PC 3rd, Coe A, Chen CA, O'Brien MJ, Heeren TC.

Ann Intern Med. 2013 Jul 2;159(1):13-20. doi: 10.7326/0003-4819-159-1-201307020-00004.

15.

Aspirin use and risk of colorectal cancer according to BRAF mutation status.

Nishihara R, Lochhead P, Kuchiba A, Jung S, Yamauchi M, Liao X, Imamura Y, Qian ZR, Morikawa T, Wang M, Spiegelman D, Cho E, Giovannucci E, Fuchs CS, Chan AT, Ogino S.

JAMA. 2013 Jun 26;309(24):2563-71. doi: 10.1001/jama.2013.6599.

16.

Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology.

Ogino S, Lochhead P, Giovannucci E, Meyerhardt JA, Fuchs CS, Chan AT.

Oncogene. 2014 Jun 5;33(23):2949-55. doi: 10.1038/onc.2013.244. Epub 2013 Jun 24. Review.

17.

The effect of copy number variation in the phase II detoxification genes UGT2B17 and UGT2B28 on colorectal cancer risk.

Angstadt AY, Berg A, Zhu J, Miller P, Hartman TJ, Lesko SM, Muscat JE, Lazarus P, Gallagher CJ.

Cancer. 2013 Jul 1;119(13):2477-85. doi: 10.1002/cncr.28009. Epub 2013 Apr 10.

18.

Analgesic use in relation to sex hormone and prolactin concentrations in premenopausal women.

Bauer SR, Fortner RT, Gates MA, Eliassen AH, Hankinson SE, Tworoger SS.

Cancer Causes Control. 2013 Jun;24(6):1087-97. doi: 10.1007/s10552-013-0186-0. Epub 2013 Mar 21.

19.

Appearance of attenuated intestinal polyposis during chronic non-steroidal anti-inflammatory drugs use.

Freeman HJ.

World J Gastrointest Pharmacol Ther. 2012 Dec 6;3(6):100-2. doi: 10.4292/wjgpt.v3.i6.100.

20.

Endobronchial miRNAs as biomarkers in lung cancer chemoprevention.

Mascaux C, Feser WJ, Lewis MT, BarĂ³n AE, Coldren CD, Merrick DT, Kennedy TC, Eckelberger JI, Rozeboom LM, Franklin WA, Minna JD, Bunn PA, Miller YE, Keith RL, Hirsch FR.

Cancer Prev Res (Phila). 2013 Feb;6(2):100-8. doi: 10.1158/1940-6207.CAPR-12-0382. Epub 2012 Dec 26.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk